Literature DB >> 12212904

The CERN-EU high-energy reference field (CERF) facility for dosimetry at commercial flight altitudes and in space.

A Mitaroff1, M Silari Cern.   

Abstract

A reference facility for the calibration and intercomparison of active and passive detectors in broad neutron fields has been available at CERN since 1992. A positively charged hadron beam (a mixture of protons and pions) with momentum of 120 GeV/c hits a copper target, 50 cm thick and 7 cm in diameter. The secondary particles produced in the interaction traverse a shield, at 90 degrees with respect to the direction of the incoming beam. made of either 80 to 160 cm of concrete or 40 cm of iron. Behind the iron shield, the resulting neutron spectrum has a maximum at about 1 MeV, with an additional high-energy component. Behind the 80 cm concrete shield, the neutron spectrum has a second pronounced maximum at about 70 MeV and resembles the high-energy component of the radiation field created by cosmic rays at commercial flight altitudes. This paper describes the facility, reports on the latest neutron spectral measurements, gives an overview of the most important experiments performed by the various collaborating institutions over recent years and briefly addresses the possible application of the facility to measurements related to the space programme.

Entities:  

Mesh:

Year:  2002        PMID: 12212904     DOI: 10.1093/oxfordjournals.rpd.a006075

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  4 in total

1.  RBE of quasi-monoenergetic 60 MeV neutron radiation for induction of dicentric chromosomes in human lymphocytes.

Authors:  R Nolte; K-H Mühlbradt; J P Meulders; G Stephan; M Haney; E Schmid
Journal:  Radiat Environ Biophys       Date:  2005-11-10       Impact factor: 1.925

2.  A novel experimental approach to characterize neutron fields at high- and low-energy particle accelerators.

Authors:  Saverio Braccini; Pierluigi Casolaro; Gaia Dellepiane; Isidre Mateu; Lorenzo Mercolli; Andrea Pola; Dario Rastelli; Paola Scampoli
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

3.  Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.

Authors:  Steve Braunstein; Jean L Nakamura
Journal:  Front Oncol       Date:  2013-04-03       Impact factor: 6.244

4.  Potential benefit of retrospective use of neutron monitors in improving ionising radiation exposure assessment on international flights: issues raised by neutron passive dosimeter measurements and EPCARD simulations during sudden changes in solar activity.

Authors:  Marina Poje Sovilj; Branko Vuković; Vanja Radolić; Igor Miklavčić; Denis Stanić
Journal:  Arh Hig Rada Toksikol       Date:  2020-06-29       Impact factor: 2.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.